A forodesine-based regimen as a therapeutic option for PTCL-NOS with Central nervous system involvement.
作者信息
Doi Yukiko, Yokota Takafumi, Shibayama Hirohiko, Matsumoto Kana, Kurashige Masako, Nozaki Kenji, Fujita Jiro, Fukushima Kentaro, Hosen Naoki
机构信息
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, Kyoto, Japan.
出版信息
Leuk Lymphoma. 2022 Apr;63(4):1013-1015. doi: 10.1080/10428194.2021.2005043. Epub 2021 Dec 2.
Abstract
摘要
Zotero 插件